At the time of writing, Apyx Medical Corp [APYX] stock is trading at $3.99, up 2.57%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The APYX shares have gain 14.33% over the last week, with a monthly amount glided 7.26%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Apyx Medical Corp [NASDAQ: APYX] stock has seen the most recent analyst activity on December 16, 2025, when Roth Capital initiated its Buy rating and assigned the stock a price target of $6. Previously, Citizens JMP upgraded its rating to Mkt Outperform on November 14, 2025. On November 12, 2025, upgrade upgraded it’s rating to Mkt Outperform but maintained its price target of $8 on the stock. BTIG Research started tracking the stock assigning a Neutral rating. Stephens initiated its recommendation with a Overweight and recommended $8 as its price target on July 14, 2023. Lake Street started tracking with a Buy rating for this stock on May 20, 2022, and assigned it a price target of $12. In a note dated April 02, 2019, Dougherty & Company reiterated an Buy rating on this stock and revised its target price from $12 to $9.
For the past year, the stock price of Apyx Medical Corp fluctuated between $0.76 and $4.44. Currently, Wall Street analysts expect the stock to reach $6 within the next 12 months. Apyx Medical Corp [NASDAQ: APYX] shares were valued at $3.99 at the most recent close of the market. An investor can expect a potential return of 50.38% based on the average APYX price forecast.
Analyzing the APYX fundamentals
According to Apyx Medical Corp [NASDAQ:APYX], the company’s sales were 47.90M for trailing twelve months, which represents an 12.10% jump. Gross Profit Margin for this corporation currently stands at 0.63% with Operating Profit Margin at -0.2%, Pretax Profit Margin comes in at -0.3%, and Net Profit Margin reading is -0.3%. To continue investigating profitability, this company’s Return on Assets is posted at -0.25, Equity is -1.54 and Total Capital is -0.2. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of6.71.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.
Ratios To Look Out For
It is important to note that Apyx Medical Corp [NASDAQ:APYX] has a current ratio of 4.44. As well, the Quick Ratio is 3.61, while the Cash Ratio is 2.29. Considering the valuation of this stock, the price to sales ratio is 3.42, the price to book ratio is 25.80.
